
Featured
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing the Gut in Landmark Study
An experimental drug called DT-109, developed at Michigan Medicine, has reversed severe fatty liver disease (MASH) in animal studies by restoring gut ...
Read Full Story →